The Great Reset: Bill Gates & Jeff Bezos invested in Synchron's brain implant project to compete with Elon Musk's Neurolink.

It seems like the World Economic Forum has finally moved away from Elon Musk's world ever since Musk's departed from the Davos' crowd. The WEF has found a replacement for Musk's Neuralink which is supposed to be part of their transhumanism agenda for 2030 and beyond.

"So our old friend Bill Gates & Amazon founder Jeff Bezos put $75 million dollars into a company called Synchron. This company is a surgery free human computer integration that has already been approved by the FDA to run human trials, where Elon Musk's Neurolink hasn't been approved for that yet. So in this video the Kwak Brothers explore the dangers of this product and how it can increase the influence of overlord Gates and his evil intentions."

Note: In this video – the FDA is controlled by the World Economic Forum/globalists through Big Pharma.

Location: United States

Comments

Post a Comment

Popular posts from this blog

WHO Pandemic Treaty: 'It's worse than we thought' – Exposing the truth on the 2025 adopted treaty.

Image
"They learned in the middle of 2021 that big pharma was not big enough. They want billions of dollars to finance the expansion of big pharma's manufacturing distribution network through poor nations who really don't have the money to do that. But the oligarchs in those nations see dollar signs." "This is just the WHO being the marketing promotion arm and now investment facilitator for big pharma to grow their industry in nations that maybe were more natural based and did far better because they used remedies that made more sense to them rather than ventilators and remdesivir and all the mRNA injections. "Now it not the time to think they have won. Quite frankly, they did a really good job of messing with everybody's head, putting lipstick on a pig, taking a failure to complete the negotiations, make it look like they've agreed to something, but it say right in the document they cannot sign it until they finish negotiating the pathogen access and bene...
Read more